GLMD vs. GOLY
GLMD (Galmed Pharmaceuticals Ltd.) is a stock, while GOLY (Strategy Shares Gold-Hedged Bond ETF) is Nontraditional Bonds fund tracking the Solactive Gold-Backed Bond Index. Over the past 5 years, GLMD returned -74.72%/yr vs 5.64%/yr for GOLY. At a 0.09 correlation, their price movements are largely independent.
Performance
GLMD vs. GOLY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with GLMD having a -23.78% return and GOLY slightly lower at -24.89%.
GLMD
- 1D
- 1.40%
- 1M
- -1.40%
- YTD
- -23.78%
- 6M
- -35.00%
- 1Y
- -67.31%
- 3Y*
- -75.82%
- 5Y*
- -74.72%
- 10Y*
- -51.88%
GOLY
- 1D
- -1.69%
- 1M
- -8.50%
- YTD
- -24.89%
- 6M
- -27.50%
- 1Y
- -9.04%
- 3Y*
- 15.20%
- 5Y*
- 5.64%
- 10Y*
- —
GLMD vs. GOLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -23.78% | -76.47% | -41.58% | -93.93% | -72.53% | -26.91% |
GOLY Strategy Shares Gold-Hedged Bond ETF | -24.89% | 57.98% | 19.82% | 12.74% | -19.96% | -1.40% |
Correlation
The correlation between GLMD and GOLY is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since May 18, 2021 | 0.09 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. GOLY — Risk / Return Rank
GLMD
GOLY
GLMD vs. GOLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Strategy Shares Gold-Hedged Bond ETF (GOLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | GOLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.45 | ||
| Sortino ratioReturn per unit of downside risk | -0.85 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 0.98 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.84 | -0.25 | -0.59 |
| Martin ratioReturn relative to average drawdown | -1.16 | -0.60 | -0.56 |
Loading charts...
Drawdowns
GLMD vs. GOLY - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, which is greater than GOLY's maximum drawdown of -36.08%. Use the drawdown chart below to compare losses from any high point for GLMD and GOLY.
Loading charts...
Drawdown Indicators
| GLMD | GOLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -36.08% | -63.91% |
Max Drawdown (1Y)Largest decline over 1 year | -79.86% | -36.08% | -43.78% |
Max Drawdown (3Y)Largest decline over 3 years | -98.84% | -36.08% | -62.76% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -36.08% | -63.84% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | — | — |
Current DrawdownCurrent decline from peak | -99.98% | -35.19% | -64.79% |
Average DrawdownAverage peak-to-trough decline | -76.07% | -12.06% | -64.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.02% | 14.99% | +43.03% |
Volatility
GLMD vs. GOLY - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 49.40% compared to Strategy Shares Gold-Hedged Bond ETF (GOLY) at 9.36%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than GOLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | GOLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 49.40% | 9.36% | +40.04% |
Volatility (6M)Calculated over the trailing 6-month period | 74.20% | 30.58% | +43.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 93.71% | 33.78% | +59.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.70% | 22.57% | +144.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.16% | 22.42% | +115.74% |
Dividends
GLMD vs. GOLY - Dividend Comparison
GLMD has not paid dividends to shareholders, while GOLY's dividend yield for the trailing twelve months is around 9.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GOLY Strategy Shares Gold-Hedged Bond ETF | 9.80% | 7.22% | 3.85% | 2.94% | 2.57% | 1.11% |
Frequently Asked Questions
GLMD and GOLY have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (49.40%) compared to GOLY (9.36%). In terms of maximum drawdown, GLMD dropped -99.99% vs GOLY's -36.08%.
GOLY currently has the higher Sharpe Ratio (-0.27 vs -0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and GOLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer